Skip to content

A Clinical Study on the Effect of Rasnadi Ghrita and Yog Basti in Children with Spastic Cerebral Palsy

Clinical Evaluation of Rasnadi Ghrita and Yog Basti in Spastic Cerebral Palsy in Children: A Single Arm Open Label Study - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105915
Enrollment
30
Registered
2026-03-11
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G800- Spastic quadriplegic cerebral palsy

Interventions

None listed

Sponsors

Post Graduate Institute of Ayurved DSRRAU Jodhpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children aged 1 to 16 years of both sexes Clinical diagnosis of spastic cerebral palsy based on characteristic signs and symptoms Mild to moderate intellectual disability associated with cerebral palsy Parents or guardians willing to participate and commit to study follow up for at least 3 months

Exclusion criteria

Exclusion criteria: Children aged below 1 year or above 16 years Presence of chronic systemic diseases such as Hridroga Prameha Vrikka Yakrit Vikara or any other congenital disease Children with progressive neurological disorders Severe physical disability that limits participation Other types of cerebral palsy such as dyskinetic extrapyramidal or mixed forms Quadriplegic cerebral palsy with status epilepticus History of recent orthopedic surgery casting splinting or fixed contractures Caregivers unwilling to provide informed consent

Design outcomes

Primary

MeasureTime frame
Therapeutic efficacy of Rasnadi Ghrita and Yog Basti in improving motor function in spastic cerebral palsyTimepoint: 96 DAYS

Secondary

MeasureTime frame
Reduction of spasticity (MAS) Efficacy on Ayurvedic and modern clinical parameters (GMFCS, ADL, quality of life) Analytical standardization and quality assessment of trial drugs Timepoint: 96 DAYS

Countries

India

Contacts

Public ContactProf Dr Harish Kumar Singhal

Post Graduate Institute of Ayurveda

ayurharish14@gmail.com8619892143

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026